Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

the Insulin Resistance in Recurrent Miscarriage IN RECURRENT ABORTION

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02088424
Recruitment Status : Unknown
Verified March 2014 by mohamed ahmed selem, Ain Shams University.
Recruitment status was:  Not yet recruiting
First Posted : March 17, 2014
Last Update Posted : March 17, 2014
Sponsor:
Information provided by (Responsible Party):
mohamed ahmed selem, Ain Shams University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
THE INSULIN RESISTANCE IN RECURRENT ABORTION

Condition or disease Intervention/treatment
Recurrent Abortion Other: insulin resistance(fasting glucose/fasting insulin)

Detailed Description:
THE ROLE OF INSULIN RESISTANCE IN RECURRENT ABORTION
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 30 participants
Observational Model: Case-Control
Time Perspective: Cross-Sectional
Target Follow-Up Duration: 6 Months
Official Title: Insulin Resistance and Recurrent Abortion
Study Start Date : March 2014
Estimated Primary Completion Date : November 2014
Estimated Study Completion Date : April 2015

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
group A
cases with recurrent abortion with insulin resisance
 Other: insulin resistance(fasting glucose/fasting insulin)
insulin resistance(fasting glucose/fasting insulin )
GROUP B
cases that are pregnant with no history of recurrent abortion with no insulin resistance
 Other: insulin resistance(fasting glucose/fasting insulin)
insulin resistance(fasting glucose/fasting insulin )


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. fasting blood glucose [ Time Frame: 3 month ]
    Click here for more information about this study: the role of insulin resistance in recurrent abortion


Secondary Outcome Measures :
  1. fasting Insulin [ Time Frame: 3 month ]

Other Outcome Measures:
  1. oral glucose tolerance test [ Time Frame: 3 month ]

Biospecimen Retention:   Samples Without DNA
whole blood

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   23 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
  1. Women in the child bearing period between 23-40 years.
  2. All patients are pregnant.
  3. The gestational age of both groups 6-13 weeks
Criteria

Inclusion Criteria:

  1. Women in the child bearing period between 23-40 years.
  2. All patients are pregnant.
  3. The gestational age of both groups 6-13 weeks

Exclusion Criteria:

  1. Patients with gestational diabetes and gestational impaired glucose tolerance.
  2. The patients who took medication that could affect glucose metabolism at the time of the study
  3. Patients with other causes of recurrent abortion as(thyroid dysfunction, uterine anomalies chromosomal abnormalities, antiphspholipid antibody syndrome, uterine anomalies and TORCH syndrome).
  4. Patients with PCOS.
  5. Obese patients(BMI>30)
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02088424


Contacts
Layout table for location contacts
Contact: mohamed a selem, master 00201116724786 drghost_3000@yahoo.com

Locations
Layout table for location information
Egypt
Ain shams maternity hospital
Cairo, Egypt
Contact: ABDELLATIF G ELKHOLY, M D         
Principal Investigator: ABDELLATIF G ELKHOLY, M D         
Sponsors and Collaborators
Ain Shams University
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Layout table for additonal information
Responsible Party: mohamed ahmed selem, THE ROLE OF INSULIN RESISTANCE IN RECURRENT MISCARRIAGE, Ain Shams University
ClinicalTrials.gov Identifier: NCT02088424    
Other Study ID Numbers: mohd-1978
First Posted: March 17, 2014    Key Record Dates
Last Update Posted: March 17, 2014
Last Verified: March 2014
Additional relevant MeSH terms:
Layout table for MeSH terms
Abortion, Habitual
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases
 Abortion, Spontaneous
Pregnancy Complications
Insulin
Hypoglycemic Agents
Physiological Effects of Drugs